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ABSTRACT
We describe the cloning and characterization of
a human homolog of the yeast transcription/RNA-
processing factor Ssu72, following a yeast two-
hybrid screen for pRb-binding factors in the prostate
gland. Interaction between hSsu72 and pRb was
observed in transfected mammalian cells and
involved multiple domains in pRb; however, so far,
mutual effects of these two factors could not be
demonstrated. Like the yeast counterpart, mamma-
lian Ssu72 associates with TFIIB and the yeast
cleavage/polyadenylation factor Pta1, and exhibits
intrinsic phosphatase activity. Mammals contain a
single ssu72 gene and a few pseudogenes. During
mouse embryogenesis, ssu72 was highly expressed
in the nervous system and intestine; high expression
inthenervoussystempersistedinadultmiceandwas
also readily observed in multiple human tumor cell
lines. Both endogenous and ectopically expressed
mammalian Ssu72 proteins resided primarily in the
cytoplasm and only partly in the nucleus.
Interestingly, fusion to a strong nuclear localization
signalconferrednuclearlocalizationonlyinafraction
oftransfectedcells,suggestingactivetetheringinthe
cytoplasm. Suppression of ssu72 expression in
mammalian cells by siRNA did not reduce prolifera-
tion/survival, and its over-expression did not affect
transcription of candidate genes in transient reporter
assays. Despite high conservation, hssu72 was
unable to rescue an ssu72 lethal mutation in yeast.
Together, our results highlight conserved and
mammalian specific characteristics of mammalian
ssu72.
INTRODUCTION
Transcription by RNA polymerase II is coupled to RNA
processing, including capping, splicing and cleavage/
polyadenylation. The C-terminal repeat (CTD) of RNA pol
II orchestrates both processes by recruiting RNA processing
factors (1–4). Indeed, CTD directly binds polyadenylation
factors and its truncation inhibits transcript cleavage in vivo
(5,6). For instance, the cleavage-polyadenylation-speciﬁcity-
factor (CPSF) is recruited to the promoter by interaction with
TFIID.Aftertranscriptionstarts,CPSFdissociatesfromTFIID
and becomes associated with CTD (7). The CTD undergoes
cyclic phosphorylation and dephosphorylation allowing
transcription initiation and re-initiation by RNA pol II (8).
Recent evidence implicates a novel yeast factor, Ssu72,
in both CTD dephosphorylation and RNA processing/
termination.
Yeast Ssu72 was initially identiﬁed by Hampsey’s group (9)
in a screen for suppressors of sua7-1, a cold-sensitive mutation
in yeast TFIIB, hence Ssu72 (Suppressor of sua7-1 clone 2).
The sua7-1 mutation shifts transcription start site selection
downstream at the ADH1 promoter; the ssu72 mutation
combined with sua7-1 induces further shift downstream. A
null mutation in ssu72 is lethal. A screen for suppressors of
a temperature-sensitive ssu72 strain identiﬁed Rpb2, the
second largest subunit of RNA pol II (10). Accordingly,
biochemical analysis revealed direct Ssu72–Rbp2 and
Ssu72–TFIIB physical interactions (10,11). Mutation in
ssu72 disrupts the expression of a subset of yeast genes,
such as CYC1 (10). Similar repression was observed when
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doi:10.1093/nar/gki171the CYC1 promoter, fused to a reporter gene, was expressed in
mutant ssu72 cells in transient transfection experiments,
indicating that Ssu72 affects promoter strength directly (10).
A genetic screen for factors that can rescue a temperature-
sensitive ssu72 strain identiﬁed Fcp1, the only known RNA
pol II CTD phosphatase, and consistent with this, Ssu72
harbors intrinsic phosphatase activity (12,13). Recent analysis
revealed that Ssu72 dephosphorylates Ser-5 in the CTD of
RNA pol II, and together with Fcp1, which targets Ser-2,
regenerates initiation competent hypo-phosphorylated RNA
pol II (14). The yeast Ssu72 also has a phosphatase-
independent function. Large-scale analysis of protein
complexes in yeast identiﬁed Ssu72 as a component of a
cleavage and polyadenylation factor (CPF) complex (15).
Ssu72 interacts directly with the Pta1 subunit of CPF and is
implicated in transcript cleavage and termination (16–19).
The retinoblastoma tumor suppressor, pRb, controls cell
proliferation, survival and differentiation and its inactivation
contributes to the progression of most human malignancies
(20). pRb exerts diverse biological effects by interacting with
over 100 proteins, most of which are involved in transcrip-
tional regulation (21). So far, pRb was documented to employ
three mechanisms of transcription repression. First, pRb
directly interacts and quenches the trans-activation domain
of transcription activators, such as E2Fs (22). Second, once
bound to an activator on promoter DNA, pRb recruits
chromatin-modifying enzymes, such as histone deacetylases
(HDACs), via LxCxE motifs in these proteins, and further
silences gene expression (23). Third, pRb binds components
of the pre-initiation complex, such as TAFII250, and may
directly affect its assembly (24). In addition to transcriptional
repression, pRb also binds tissue-speciﬁc differentiation
factors, such as myogenin, C/EBP and CBFA1, and positively
participates in the transcriptional activation of lineage-speciﬁc
markers (25–27). In a screen for mammary- and prostate
gland-speciﬁc cDNA libraries for pRb-binding factors, we
here describe the identiﬁcation and characterization of
hSsu72, a human homolog of yeast Ssu72.
MATERIALS AND METHODS
Plasmids
Details on the construction of the following plasmids are
available upon request. For yeast two-hybrid screens, we
generated pAS1-CYH2-Rb, RbDK11 and D22. For yeast
complementation studies: pRS316-yssu72, pYES-yssu72,
pYES-Myc-yssu72, pYES-hssu72 and pYES-Myc-hssu72.
GST-Rb was used to create GST-RbDA, -RbDC, -RbD22DC
and -RbDLxCxE [derived from a plasmid kindly obtained
from F. Dick (28)]. GST-Pta1 was a gift from X. He and
C. L. Moore. Mutant Rb and ssu72 alleles were transferred
into pHAT vectors (Clontech).Human ssu72-NI-1pseudogene
was cloned by PCR from human genomic DNA. Mouse ssu72
was cloned into (pBS) by RT–PCR. Human ssu72 was sub-
cloned into pTAG-2HA or a pcDNA3 vector into which Myc
or Flag epitopes were added in frame to the N-terminus.
SV40 TAg-NLS
PPKKKRKV
CCC CCG AAG AAA AAG CGG AAG GTC
was added between the Myc and hssu72 sequence. pcDNA3-
Myc and Myc-NLS-hssu72 deletion mutants were generated
by cloning linkers between restriction enzyme sites in hssu72.
For tethering to promoters, hSsu72 was fused in frame with the
DNA-binding domain of Lex. pLex, GAL-myc, GAL-Rb
and the reporter X4G2-luciferase [4 GAL4 and 2 LexA
DNA-binding elements fused upstream of the hsp70 promoter
(29)] were gifts from R. Bremner.
Yeast interactive screen and complementation analysis
Yeast two-hybrid screens for pRb interacting factors were
performed following the Clontech Matchmaker GAL4 two-
hybrid user manual. Prior to library screening, conditions were
optimized using the E1A-activation domain as prey. A human
prostate Matchmaker cDNA library (catalog no. HL4037AH)
in pACT2 vector was purchased from Clontech and screened
as speciﬁed by the manufacturer. Plasmid DNA was recovered
from putative yeast clones using the following protocol.
Fresh (2–4 day old) yeast colonies were inoculated into 5 ml
of SD/-Trp-Leu liquid medium, vortex vigorously to resus-
pend the cells and rotated 230–250 r.p.m. at 30 C overnight.
The yeast cells were centrifuged at 14 000 r.p.m. for 5 min.
The supernatant was decanted and the pellets were resus-
pended in the same buffer ( 50 ml). An aliquot of 10 ml
lyticase solution was added and the samples were rotated at
200–250 r.p.m. for 30–60 min at 37 C. An aliquot of 20 mlo f
10%SDSwasaddedfollowedbyvigorousvortexingfor1min.
The samples were subject to at least one cycle of freeze/thaw
(at  20 C) and vortexed again to ensure complete lysis of the
cells. The volume of the samples was adjusted to 200 mli nT E
buffer (pH 7.0), and 200 ml of phenol:chloroform:isoamyl
alcohol (25:24:1) was added. After high-speed vortexing for
5min,thesampleswerespundownat14000r.p.m.for10min.
The supernatant was collected, 8 ml of 10 M ammonium
acetate was added and the DNA samples were further puriﬁed
on Qiagen mini-prep columns. The puriﬁed plasmid DNA was
transformed and ampliﬁed in competent DH5a bacteria.
Plasmid DNA was analyzed using PCR, restriction enzyme
digestions and sequencing, and subsequently re-transformed
and tested in yeast Y190 containing the different Rb baits.
For complementation analysis, ssu72(+/ ) diploid yeast
strain [ATCC-4021990; (30)] was transformed with human
or yeast ssu72 expression vectors using lithium acetate. Trans-
formants were selected on SD-URA( ) medium supplemented
with glucose (2%). Ectopic proteinexpression was assessed by
the SDS–UREA method from liquid cultures grown in YEPD
then induced with YEP supplemented with galactose (2%)
overnight. Sporulation was induced in 2% potassium acetate.
Tetrads were isolated and dissected on SD supplemented with
galactose (2%) and all amino acids. Dissected cultures were
replica plated onto YEPD- G418 or SD-URA
( ) medium to
assess growth and genotype.
Antibodies
Rabbit polyclonal antibodies to hSsu72 were generated by
Exalpha Biologicals, Inc. (Boston MA), following immuniza-
tion with puriﬁed eluted GST-hSsu72 that was extensively
dialyzed against phosphate-buffered saline (PBS). These
anti-hSsu72 antibodies are now available (catalog
no. X1562P). Monoclonal a-Flag and a-Myc (Cell Signaling
Nucleic Acids Research, 2005, Vol. 33, No. 2 465Technology) were used at a dilution of 1:1500 for western
blotting and 2.5 mg per sample for immunoprecipitation.
Monoclonal anti-a-tubulin, Sigma catalog no. T-5168, was
used at 1:1000 dilution for western blotting.
Western blot and co-immunoprecipitation analysis
Cells were transfected with the indicated plasmids using poly-
ethylenimine (Aldrich catalog no. 40,8727, protocol available
upon request). Three days later, plates were placed on ice and
washed twice with ice-cold PBS. Cells were scrapped in PBS,
transferred to 1.5 ml microfuge tubes and centrifuged at
3000–4000 r.p.m. for 5 min at 4 C. Cell pellets were resus-
pended in 1 ml NTEN buffer (100 mM NaCl, 0.5% NP-40,
50 mM Tris–HCl, pH 7.6) plus proteinase inhibitors and
phenylmethlysulfonyl ﬂuoride (PMSF), and disrupted by
drawing through a needle 5–10 times on ice, followed by
additional incubation on ice for 15 min. The lysates were
cleared by centrifugation at 13 000 r.p.m. for 20 min and
the supernatants were transferred to new tubes. Aliquots of
40 ml were withdrawn for straight western blots. To the rest of
the lysates, a-Myc antibodies (2.5 mg) were added and placed
ona rocking platform at 4 C overnight. Pre-washed (3–4 times
NTEN) 100 ml secondary antibody-agarose was added for 30–
60 min. Protein complexes on beads were washed six times in
NTEN plus 0.1% SDS and immunoblotted as described
previously (31).
Immunostaining
COS7 cells were seeded on coverslips in DMEM medium
supplemented with fetal bovine serum (FBS) (10%), then
transfected with 1–2 mg of recombinant or control pcDNA3
vector DNA.Twenty-four hours following transfection, cover-
slips were rinsed with PBS, ﬁxed in ice-cold methanol
(30 min), then washed in PBS (3 · 10 min). After blocking
in 1% BSA/PBS for 1 h, a-Myc or a-hSsu72 primary anti-
bodies were added in blocking solution for 1 h. Coverslips
were rinsed with PBS (3 · 10 min) and incubated with
ﬂuorescein isothiocyanate (FITC) or Rhodamine-conjugated
secondary antibodies (1:200 dilution, 1% BSA/PBS) in
addition to DAPI (40,60-diamidino-2-phenylindole, dihydro-
chloride). Cover slips were rinsed with PBS (3 · 10 min)
and ﬁnally mounted using Dako ﬂuorescent mounting medium
(S3023). Leptomycin B (Sigma catalog no. L2913), was added
to a ﬁnal concentration of 10 nM for a duration of 2 h prior to
immunostaining.
Purification of GST- and Hat-fusion proteins and
GST-pull down
Hat-tagged proteins were puriﬁed on Talon Metal Afﬁnity
Resins according to the manufacturer’s recommendations
(Clontech). For GST-fusion proteins, overnight bacterial
cultures were diluted 1:10 in 2–3 l of 2YT (Ampicillin,
100 mg/ml), and cultures were grown for 1.5 h at 37 C.
Isopropyl-b-D-thiogalactopyranoside was added to a ﬁnal con-
centration of 0.1 mM and cultures were shaken for another
2.5 h at 30 C/280 r.p.m. Cultures were spun down at 5000
r.p.m. for 15 min at 4 C and resuspended in 3 ml NNTE buffer
(500 mM NaCl, 0.5% NP-40, 50 mM Tris–HCl, pH 7.6, 5 mM
EDTA) containing PMSF. The resuspended bacteria were
transferred to 30 ml spin tubes at 4 C, sonicated 3 · 20 s
on ice and spun at 10 000 r.p.m. for 20 min at 4 C. The
supernatant containing the fusion proteins were mixed with
glutathione SepharoseTM 4B beads pre-washed three times in
0.5 ml ice-cold NNTE buffer in 15 ml FALCON tubes and
rocked for 30–60 min at 4 C. The beads-GST fusion proteins
were then washed in NNTE buffer and three times in NTEN
bufferat4 Cand ﬁnallyresuspendedin 500ml NTEN:glycerol
(50:50) for storage for up to 10 days at  20 C. For pull-down
experiments, GST-beads (amounts assessed from Coomassie
blue staining ofprotein gels with BSAas control)were washed
in NTEN three times, rocked with protein lysates or
Hat-tagged proteins (Hat-Ssu72) for 2 h at 4 C and washed
with NTEN buffer six times.
Phosphatase assay
Phosphataseactivitywasperformed bymonitoringthe produc-
tion of p-nitrophenylate from p-nitrophenylphosphate (pNPP).
For phosphatase inhibition assay, excess GST-proteins on
beads were mixed with minimal amounts of puriﬁed
Hat-hSsu72 protein, which produced phosphatase activity
within 30 min, in a ﬁnal volume of 98 ml NTEN buffer in
ELISA plates (MICROTEST
TM96, FALCON). After agitation
at 37 C for 30 min at 100 r.p.m., 2 ml of 1 M pNPP was added
and incubation continued for additional 30–60 min. The reac-
tion was stopped by the addition of 3.8 vol of 0.1 M NaOH and
optical density was measured at 405 nm with Vmax ELISA
reader (Molecular Devices Inc.).
Small interfering RNA (SiRNA) and MTT analysis
Custom sense and anti-sense RNA oligonucleotides targeting
the sequence AAC AGG GAC TCA CGT GAA GCT or AAG
ACC TGT TTG ATC TGA TCC of hssu72 were purchased
from Dharmacon Research Inc. and annealed according to the
manufacturer’s recommendations. COS7 cells were seeded at
50% conﬂuency in DMEM medium supplemented with 10%
FBS and transfected for 2 or 3 successive days using 0.2 nM of
either annealed duplex targeting hssu72 or two non-
complementary RNA oligonucleotides (control), using the
Oligofectamine reagent (Invitrogen). The day following the
last transfection, siRNA-treated and controls cells were har-
vested by trypsinization and the total number of cells was
determined by Trypan blue exclusion staining. A portion
of the harvested cells was seeded in triplicates onto 96 well
plates at 2 · 10
3 cells/well. About 6 or 18 h later, cultures
were treated with MTT [3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium-bromide; Sigma M2128] at a ﬁnal con-
centration of 0.8 mg/ml in DMEM (10% FBS) for 1 h. Cultures
were lysed overnight, and absorbency was determined at
570 nm using an ELISA plate reader. The remaining harvested
cells were lysed using a Triton-X based protein extraction
buffer [50 mM Tris, pH 7.5, 150 mM NaCl, 10% (v/v)
Glycerol, 1% (v/v) Triton X-100 and 1 mM EGTA] for
western analysis to conﬁrm the effect of siRNA treatment
on hssu72 expression.
Northern blot analysis
Total RNA from cultured cells or fresh mouse tissues was
prepared using the Trizol reagent (Invitrogen). RNA samples
were separated electrophoretically on formaldehyde denatur-
ing agarose gels, transferred onto GeneScreen-Plus nylon
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32P-labeled hssu72, mssu72
or gapdh radioactive probes under conditions speciﬁed by the
manufacturer.
Nuclear/cytoplasmic fractionation
COS7 cultures were transiently transfected with pcDNA3-
Myc-Stra13 (nuclear marker) and pcDNA3-Myc-luciferase
(cytosol marker) and harvested by trypsinization 36–48 h
later. Cells were resuspended in swelling buffer (10 mM
Tris–HCl, pH 7.5, 10 mM KCl and 2 mM MgCl2) and the
plasma membrane was solubilized by the addition of NP-40 to
a ﬁnal concentration of 0.6%. Nuclei were collected by
centrifugation at 1000 g. The supernatant/cytoplasmic fraction
was adjusted to 10% glycerol, 150 mM NaCl. Nuclei were
rinsed once in swelling buffer then lysed in Triton-X (1%)
extraction buffer. The amount of protein lysates used from
each fraction was normalized for analysis by western blotting.
Luciferase reporter assays
COS7 or C33A cells were transiently transfected with a pGL3-
based luciferase reporter vectors, Cyclin E, p107, pG4X2
(100 ng); class B E-box elements (CACGTG) (100 ng), the
SV40 immediate early promoter (10 ng) or the Rb promoter
(100ng).ExpressionvectorspcDNA3-Myc-hSsu72,pcDNA3-
Myc-NLS-hSsu72, pcDNA3-Lex-Myc-NLS-hSsu72, Gal-Rb
or Gal-myc were co-transfected together with 250 ng
CMV-lacZ as internal control. Luciferase analysis and data
analysis was performed using standard methods as described
previously (32,33).
In situ hybridization
33P-UTP labeled sense and anti-sense riboprobes for mouse
ssu72were generatedfromlinearizedDNAtemplates usingT7
or T3 RNA polymerase (Fermentas). An aliquot of 8 mm
sections from parafﬁn-embedded embryonic tissues were
processed, hybridized (1.5 · 10
5 c.p.m./ml), washed and
counter-stained as described previously (34,35). Images
were captured using an AxioCam MRc digital camera
(Zeiss). For the dark ﬁeld phase, identical exposure time
and digital processing were used for sense and anti-sense
probes.
RESULTS
Identification of human Ssu72 following a yeast
interactive screen with a pRb bait
In an effort to identify mammary and prostate gland-speciﬁc
pRb-binding factors, we performed yeast two-hybrid screens
with pRb as bait. Previous analysis had shown that when
ectopically expressed in yeast, human pRb is highly phos-
phorylated by cyclin-dependent kinases (36). We therefore
used as bait a constitutively active pRb allele, RbDK11, in
which phosphorylation is inhibited by mutations in 11 of the
16 Ser/Thr phospho-acceptor sites in pRb (37). This has
allowed us to perform yeast two-hybrid screens at relatively
high concentrations of the His3 antagonist, 3-AT. The initial
screen was carried out in the presence of 20 mM 3-AT. A total
of 200 clones isolated after 6days of incubation were collected
and re-examined on plates containing 35 mM 3-AT.
Approximately 40% survived and were selected for DNA
isolation and shuttling into bacteria. Plasmid DNA from
unique clones, identiﬁed by PCR analysis and restriction
enzyme digestion, was puriﬁed and subjected to a second
round of screens with RbDK11 and RbD22, a non-
functional allele of pRb, as baits. In the second screen, we
used both the His3 and LacZ reporters to score for positive
clones.
Our initial screen of a mammary gland library identiﬁed
multiple factors that were all previously shown to interact with
pRb, including HSP70, Id2 and cyclin D1 (data not shown).
Screening of a prostate library identiﬁed additional factors,
four of which represented full- or near full-length human
homologs of the yeast ssu72 gene (Figure 1A and B).
When re-transformed into yeast cells and tested on His- plates
or by the lacZ reporter assay, the human ssu72 cDNA clones
interacted with pRbDK11 as well as wild-type pRb, but only
weakly with the pocket-mutant pRbD22 (data not shown).
The interaction between pRb and hSsu72 was conﬁrmed
in vitro and in transfected cells in vivo (Figure 2A and B).
Interestingly, human Ssu72 contains an LxCxE motif frequen-
tly found in pRb-binding factors (Figure 1A and B). However,
interaction between the two factors was independent of the
LxCxE motif in hSsu72 or the LxCxE-binding motif in pRb
but rather involved multiple domains in pRb (Figure 2B–E).
Despite numerous experiments, we have been so far unable to
identify a context in which a mutual effect between pRb and
hSsu72 could be demonstrated (see below and Discussion).
Mammalian hSsu72 associates with TFIIB and
yeast Pta1
We ﬁrst tested whether hSsu72 is biochemically conserved by
investigating itsability tointeractwith knownbindingpartners
ofitsyeastcounterpart. Yeast Ssu72was initially identiﬁedvia
its genetic interaction with yTFIIB; it was subsequently shown
to associate with GST-yTFIIB in pull-down experiments with
invitrolabeledSsu72(9,11).AsshowninFigure3A,GST-pull
down assays with total protein lysates of COS7 cells revealed
that endogenous mammalian TFIIB was co-precipitated in the
presence of GST-hSsu72 but not GST alone.
A second major binding partner for Ssu72 in yeast is Pta1, a
subunit of the yeast cleavage and polyadenylation complex
(16,17,38). Myc-hSsu72 was ectopically expressed in mam-
malian cells and lysates were mixed with GST-Pta1 or GST
alone. As shown in Figure 3B, Myc-hSsu72 co-sedimented in
the presence of GST-Pta1 but not GST. The interaction of
hSsu72 with GST-Pta1 appeared to be as efﬁcient as the
interaction with GST-pRb (Figure 3B). Thus, the phylogenetic
conservation of Ssu72 is sufﬁcient to allow not only intra-
species binding to TFIIB but also inter-species interaction
with the yeast factor Pta1.
Interaction with pRb, TFIIB or yeast Pta1 does not
alter hSsu72 intrinsic phosphatase activity
To conﬁrm that human Ssu72 exhibits protein phosphatase
(PPase) activity, we tested puriﬁed GST- and Hat-tagged-
hSsu72 fusion proteins in phosphatase assays using pNPP
as a substrate. Phosphatase activity was observed within
20–30 min under standard phosphatase conditions (100 mM
citrate, pH 6.5) as well as binding conditions (containing 0.5%
Nucleic Acids Research, 2005, Vol. 33, No. 2 467NP-40) (see Supplementary Material, Figure SD.1A; data not
shown). A single point mutation, converting Cystein 12 to
Serine [GST-hSsu72:C12S (12,13)] in the phosphatase
domain (VCSSNQNRS), or deletion of the entire domain
(GST-hSsu72:113–194) completely abolished phosphatase
activity (Figure SD.1A). Addition of GST-hTFIIB, GST-
Pta1 or GST-Rb did not affect hSsu72 phosphatase activity
compared with GST alone (Supplementary Material, Figure
SD.1B). Consistent with this, deletion of the phosphatase
domain (amino acids 1–12) in Hat-hSsu72 did not abolish
interaction with TFIIB, Pta1 or pRb (Figure 3C), indicating
that these factors do not interact with hSsu72 via its PPase
domain.
Human and mouse genomes encode single ssu72 genes
BLAST searches of mammalian NCBI EST databases
revealed a single expressed ssu72 cDNA sequence per species
(data not shown). Accordingly, only a single locus for ssu72
was found in the human genome (Figure 4A). Located on
chromosome1p36,itspansapproximately32kbanditscoding
region is divided into ﬁve exons. We also identiﬁed eight
intronless ssu72-related sequences, which likely represent
pseudogenes (Figure 4B). Typically, these pseudogenes dis-
play 75–85% identity with human ssu72, have different Kozak
translation initiation sequence and can be divided into three
groups according to location and similarity to one another
(Figure 4B). In silico analysis of expressed sequence tag
databases failed to detect ssu72-pseudogene sequences,
suggesting that none of them is expressed.
BLAT searches of mouse genomic sequences also revealed
a single functional ssu72 gene, located on chromosome 4
(Figure 4C). The overall organization into ﬁve exons and
the intron/exon boundaries in the human and mouse ssu72
genes are conserved (Figure 4C; data not shown). Two partial
sequences with homology to ssu72 are also present in the
mouse genome. These sequences are clearly non-functional
as they are severely truncated/mutated (Figure 4C). Thus, the
intronless homologs of ssu72 likely represent non-functional
pseudogenes; each mammalian genome, just like yeast,
appears to contain a single functional ssu72.
Identification of the ssu72 transcripts and Ssu72 protein
To assess the expression of human ssu72, we performed
northern blot analysis on RNA extracted from multiple
A
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Figure 1. MolecularcloningofhSsu72followingyeasttwo-hybridscreenwithRbDK11asabait.(A)SchematicrepresentationofhSsu72clonesrecoveredfromthe
yeast two-hybrid screen with RbDK11 as bait. The approximate size of clone no. 113 was deduced from fragment size; the exact size of the other clones was
determinedbyDNAsequencing.(B)Sequencealignmentandaminoacidconservationinhuman,mouseandyeastSsu72proteins.Thehumanandmouseproteinsare
almostidenticalwiththeexceptionofthetwoindicatedconservedsubstitutions.Reddenotesidenticalresidues;orange,similar;black,non-conserved.Notethatthe
N-terminus is generally more conserved than the C-terminus. The PPase domain and the putative LxCxE are indicated.
468 Nucleic Acids Research, 2005, Vol. 33, No. 2mammalian tumor cell lines. These included human cervical
carcinoma cells (C33A), SV40 transformed monkey kidney
cells (COS7); human cervical epithelial adenocarcinoma
(HeLa); human T lymphocytes (J-45); human transformed
kidney cells (293); and human breast adenocarcinoma
(MCF7). A doublet of different relative intensity was detected
in all cell lines (Figure 5A). The lower transcript was predo-
minant in the J-45 lymphocytes, whereas the upper transcript
 
Figure 2. Interaction of pRb and hSsu72 in vitro and in vivo.( A) COS7 cells were transfected with plasmids expressing Myc-tagged pRb, Myc-RbD22DC and/or
Flag-tagged Ssu72 as indicated. Four percent of protein lysates were analyzed directly by western blotting (lanes 1–5). The remaining lysates were immunopre-
cipitated with anti-Myc antibodies, washed extensively and immunoblotted with anti-Flag antibodies to reveal co-immunoprecipitated Flag-Ssu72. Ssu72 was co-
sedimentedonlyinthepresenceofpRb(lane9)butnotRbDD22Dc(lane10)orintheabsenceofRb(lane8).Asteriskinbothpanelsdenotesuncharacterizedproteins.
IP, immunoprecipitation; IB, immunoblot. (B–C) GST-pull down experiments demonstrating that interaction of pRb and hSsu72 is not mediated by the LxCxE-
binding site in pRb (B–C) or the LxCxE motif in Ssu72 (C). In GST-RbLxCxEmut, the LxCxE-binding domain is disrupted by I753A, N757A and M761A
substitutions(28,61).hSsu72LxCxEcontainsaLTCEEtoLTGEEsubstitution.SimilarsubstitutionofthecentralcysteinintheLxCxEmotifsinadenovirusE1Aand
human HSP75 completely disrupted the interaction of these proteins with pRb (62). The indicated proteins were expressed in COS7 cells by transfecting the
corresponding expression vectors. Lysates were mixed with the indicated GST-fusion proteins, extensively washed and immunoblotted with antibodies reactive to
HA,FlagorlargeTag,whichisconstitutivelyexpressedinCOS7cells.NotethatinteractionofpRbwithHDACandTagbutnotSsu72isdisruptedbymutationsinthe
LxCxE-binding domainin pRb. (D) Schematicrepresentation of the GST-Rb fusionprotein and variousdeletionmutantsused in the followingpanel.(E) GST-pull
down experiments of the indicated GST-Rb fusion proteins with transfected HA-hSsu72 or endogenous Tag in COS7 cells. Deletions in the A or B regions
(GST-RbDAand(GST-RbD22)orC-terminaldomain(GST-RbDC),reducebutdidnotcompletelyinhibitbindingtohSsu72;doubledeletionsofexon22andinthe
C-terminus (GST-RbDCD22) abrogated pRb- hSsu72 interaction. Coomassie staining of the GST-fusion proteins is shown. Inputs in all panels were 4%.
Nucleic Acids Research, 2005, Vol. 33, No. 2 469was more abundant in the other cell types, in particularly the
two kidney-derived cells 293 and COS7. The nature of these
different transcripts, which may originate from alternative
splicing or promoter usage, is unknown. Northern blots
performed in parallel with the hssu72-NI-1 pseudogene
probe produced only low levels of signals possibly due to
cross hybridization with hssu72 (data not shown).
To identify endogenous hSsu72, we raised rabbit polyclonal
antibodies against full-length GST-hSsu72 (see Materials and
Methods). Speciﬁcity of the hSsu72 sera was veriﬁed in a
Figure 3. Human hSsu72 interacts with TFIIB and yeast Pta1. (A) Interaction of hSsu72 with TFIIB. COS7 lysates were mixed with GST-hSsu72 or GST proteins
immobilized on beads, washed extensively and immunoblotted with antibodies reactive to TFIIB. GST-hSsu72 but not GST efficiently precipitated endogenous
TFIIB.(B)InteractionofhSsu72withyeastPta1.COS7cellstransfectedwithpcDNA3-Myc-Ssu72orvectoralonewerelysedandmixedwithGST-RborGST-Pta1
proteins,washedextensivelyandimmunoblottedwithantibodiesreactivetoaMyc-specificepitope.BothhumanRbandyeastPta1efficientlyinteractedwithhuman
Ssu72.(C)Hat-hSsu72orHat-hSsu72D1-12,containinganin-framedeletionthatremovesthePPasedomain,waspurifiedonTalonresins,mixedwiththeindicated
GST-fusion proteins, washed extensively and immunoblotted with polyclonal antibodies reactive to hSsu72. Pta1, pRb and TFIIB interacted with both Hat-hSsu72
and Hat-hSsu72D1-12.
Figure 4. Structural organization of mammalian ssu72 genes. (A) Structural organization of human ssu72 on chromosome 1. The intron/exon boundaries were
deducedfromthegenomicsequence.Exon1denotesonlythecodingregion(transcriptionstartsiteisunknown).(B)Location,conservationandsequencesaroundthe
translationinitiationsitesinssu72anditsintronlesspseudogenes.(C)Structuralorganizationofmousessu72onchromosome4andtworelatedpseudogenes,which
are likely non-functional due to internal deletions/mutations.
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tagged hSsu72, which migrates slower than endogenous
Ssu72 on denaturing polyacrylamide gels, in the presence
or absence of GST or GST-hSsu72 as competitors. In addition,
as described below (Figure SD-2), ssu72 siRNA speciﬁcally
knocked down the expression of Ssu72 as determined by
immunoblotting with these antibodies. To assess the expres-
sion of Ssu72, we performed western blot analysis on the same
cell panel described above. A single band of  30 kDa corres-
ponding to endogenous Ssu72was observed in all the cell lines
(Figure 4B).
Ssu72 resides primarily in the cytoplasm and partly in
nucleus
To determine the subcellular localization of Ssu72, we
performed nuclear-cytoplasmic fractionation of COS7 cells
followed by western blotting. As control, we transfected the
cells with Myc-luciferase as a cytoplasmic marker and
Myc-Stra13 as a nuclear marker. While the two markers loca-
lized exclusively in the cytoplasm and nuclear fractions,
respectively, endogenous Ssu72 was found in both fractions
but predominantly in the cytosol (Figure 6A). Ectopically
expressed untagged and Myc-tagged hSsu72 isoforms also
localized primarily in the cytoplasm of transfected cells,
as was determined by immunoﬂuorescence microscopy
(Figure 6B). Notably, the yeast proteomic nuclear localization
project also assigned cytoplasmic > nuclear localization to the
yeast Ssu72 (39).
In an attempt to identify a discrete region in hSsu72
involved in the regulation of subcellular localization, we
created a series of in-frame deletions spanning the entire
hSsu72 polypeptide (Figure 6C). All the deletion mutants
localized primarily in the cytoplasm like full-length
hSsu72 (Figure 6D). Also, Leptomycin B, an inhibitor of
the nuclear export receptor, CRM1, did not induce obvious
nuclear accumulation of transfected Myc-hSsu72 (data not
shown).
Subcellular localization of hSsu72 fused to a strong
nuclear localization signal
We next asked whether fusing a strong NLS such as the SV40
large Tag, PPKKKRKV (40), to the N-terminus of hSsu72
would confer nuclear localization. The resulting protein,
NLS-hSsu72, was localized exclusively in the nucleus in
 45%, exclusively in the cytoplasm in  45%, and throughout
the cell in  10% of transfected cells (Figure 6E; data not
shown). Remarkably, when the NLS was fused in frame to
the series of internal deletion mutants, it invariably induced
complete nuclear localization in all the transfected cells
(Figure 6F). Thus, regulation of hSsu72 subcellular localiza-
tion requires the integrity of the protein entire amino acid
sequence and can be conferred at least in part by fusion to
a strong NLS.
Mouse ssu72 is dynamically regulated during
embryonic development
The widespread expression of ssu72 in multiple cell lines, our
ﬁndings that it appears to represent a unique gene in mammals
and the known function of the yeast Ssu72 in transcription/
RNA processing suggest that it is likely a ‘housekeeping’ gene
invariably expressed in all tissues. To directly examine this
conjecture, we cloned the mouse ssu72 gene and performed
northern blot analysis on multiple adult tissues. A single
hybridizing band was detected in the various tissues
(Figure 7A). Strikingly, mssu72 was expressed at low level
in most tissues but highly in the brain, suggesting that the gene
may be dynamically regulated.
To further pursue mouse ssu72 gene expression, we per-
formed radioactive in situ hybridization analysis during
embryogenesis. At embryonic (E) day 10.5, low level of
mouse ssu72 transcripts was detected throughout the embryo
with relative accumulation in spinal cord and brain folds
(Figure 7B). Thereafter, mouse ssu72 expression was further
induced in the developing nervous system and gut. At E13.5,
high expression was observed throughout the CNS both in the
ventricular (mitotic) and marginal (post mitotic) zones, in
the PNS in dorsal root (DRG) and trigeminal (TG) ganglia,
and the developing gut (Figure 7C). During fetal development,
expression in the CNS and PNS persisted, and expression in
the intestine was further induced (Figure 7D–F). Expression in
the intestine was observed throughout the mucosal villi, which
contains epithelial cells and other cell types. Thus, in both the
nervous system and gut, ssu72 appears to be expressed in
both proliferating and non-proliferating cells. High ssu72
expression was also detected in the lens (Figure 7D). In
contrast, other tissues such as liver, lung, bone, cardiac and
skeletal muscles exhibited no detectable expression of ssu72.
These results strongly implicate mouse ssu72 in the develop-
ment of a subset of tissues including the nervous system and
intestine.
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Figure 5. Identification of ssu72 transcripts and Ssu72 protein. (A) Aliquots
containing 50 mg of total RNA from the indicated cell lines were separated by
electrophoresis through a 1% agarose/formaldehyde gels, northern blotted and
probed with
32P-radiolabeled human ssu72 cDNA as a probe. Note a doublet
with variable intensity in the different cell types. Gapdh was used as internal
RNA loading control. (B) Western blot analysis of indicated cell lines with
rabbit polyclonal antibodies raised against GST-hSsu72. Note a single band of
 30 kDa in all lines. a-tubulin was used as internal protein loading control.
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COS7 cells
As ssu72 loss-of-function mutations result in lethality in
Saccharomyces cerevisiae (9), we next wished to determine
whether the gene is essential for growth or viability in
mammals. We employed siRNA technology to knockdown
ssu72 expression in mammalian cells (41,42). A dramatic
inhibition of Ssu72 expression in COS7 cells was attained
Figure 6. Regulation of mammalian Ssu72 subcellular localization. (A) Shown are duplicate COS7 cultures transiently transfected with a nuclear marker, Myc-
Stra13andacytoplasmicmarker,Myc-luciferase.Nuclearandcytoplasmicfractionswereprepared,separatedonpolyacrylamide–SDSgelsandimmunoblottedwith
anti-Myc antibody to determine the efficiency of the fractionation procedure and anti-hSsu72 antibody to reveal subcellular localization of endogenous Ssu72.
(B) Immunofluorescent localization of ectopically expressed untagged or Myc-tagged hSsu72 proteins using anti-hSsu72 or anti-Myc specific antibodies, respec-
tively.NucleiwerelabeledbyDAPIstaining.(C)SchematicstructureofMyc-hSsu72andMyc-NLS-hSsu72deletionmutants.(D)Cytoplasmiclocalizationoftwo
representative Myc-hSsu72 deletion mutants, D16-40 and D64-119. All other Myc-hSsu72 deletion mutants shown in (C) also resided in the cytoplasm (data not
shown). (E) Immunofluorescent analysis of COS7 cells ectopically expressing Myc-NLS-hSsu72 in which hSsu72 is fused to the SV40 Tag NLS. About 45% of
transfected cells exhibited complete nuclear localization (top), 45% cytoplasmic localization (bottom); the rest (10%) were found throughout the cell (data not
shown). (F) Immunofluorescent analysis of COS7 cells ectopically expressing the same two deletion mutants, D16-40 and D64-119 (D), fused to SV40 TAg NLS
(Myc-NLS-hSsu72). Both deletion mutants were completely nuclear. All other Myc-NLS-hSsu72 deletion mutants shown in (C) also exhibited exclusive nuclear
localization (data not shown). Secondary fluorescent antibodies used were Rhodamine-conjugated secondary anti-rabbit antibody (A, top) and FITC-conjugated
secondary anti-mouse antibody (all other panels).
472 Nucleic Acids Research, 2005, Vol. 33, No. 2Figure 7. Dynamic regulation of mouse ssu72 expression during development. (A) Aliquots containing 20 mg of total RNA from the indicated mouse adult tissues
weresubjectedtonorthernblotanalysiswith
32P-labeledmssu72cDNAprobe.Asloadingcontrol,theblotswerere-hybridizedwithgapdhandthelevelsof28Sand
18SribosomalRNAsrevealedbyEtBrstaining.(B–F)Radioactivesectioninsituhybridizationanalysisofssu72duringmouseembryogenesis.(B)Sagittalsectionof
an E10.5 embryo showing widespread expression most prevalent in the nervous system. (C) Bright field (BF) and dark field images of coronal sections of E13.5
embryoshybridizedwithsenseoranti-sensemousessu72asindicated.Atthisstage,ssu72expressionbecomesrestrictedtothedevelopinggutandnervoussystem,
withhighexpressioninTG,DRGandspinalcord.(D)BrightanddarkfieldimagesofsagittalsectionsofE13.5embryoswithhighexpressioninlens,TGandtheCNS
aroundthelateralventricle.(EandF)SagittalsectionsofE17.5andE18.5fetusesshowingexclusiveandhighexpressioninthenervoussystem,primarilyinDRGof
the PNS, and intestine. Other tissues including heart, liver, lung and muscles do not express significant levels of mouse ssu72.
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the N-terminus ofthe Ssu72 coding region (see Supplementary
Material, Figure SD-2). Inhibition was often observed after
two successive transfections, but maximal and reliable effects
were obtained after three transfections. Less efﬁcient inhibi-
tion of Ssu72 expression was obtained in HeLa cells, probably
reﬂecting reduced transfection efﬁciency (data not shown),
hence subsequent analysis was performed only on COS7
cells. Despite the dramatic inhibition of Ssu72 protein expres-
sion, the morphology and total number of cells were unaf-
fected as determined by microscopic examination and trypan
blue exclusion assays (Figure SD-2; data not shown) (43).
The levels of dead cells were low and similar in both
siRNA-treated and control cultures (data not shown).
Furthermore, no difference in proliferation or viability was
observed by the MTT assay, performed 6 and 18 h post
siRNA treatment (Figure SD-2). We conclude that Ssu72 is
dispensable at least in certain mammalian cells in culture or
that dramatically reduced levels of Ssu72 sufﬁce for cell
survival/proliferation.
Over-expression of native, nuclear- or DNA-targeted
hSsu72 exerts minimal effects on transcriptional
activity of candidate promoters
To test whether hSsu72 can alter gene expression in mamma-
lian cells, we performed transient luciferase (luc) reporter
assays in the absence or presence of transfected hSsu72. As
we have not yet identiﬁed transcriptional targets regulated
by Ssu72, several candidate promoters were tested.
Over-expression of hSsu72 or NLS-hSsu72 had no effect on
human RbP.luc (32) and (CACGTG)2SV40.luc (33)
(Supplementary Material, Figure SD-3). Three other promo-
ters: cyclinEP.luc, p107P.luc and DHFRP.luc were also not
responsive (data not shown). We also created a translational
fusion of hSsu72 with the DNA-binding domain of Lex (Lex-
Myc-NLS-hSsu72) and tested its effect on X4G2.luciferase,
a synthetic minimal promoter containing binding sites for
GAL4 and Lex. Again, no signiﬁcant effect was observed
when Lex-Myc-NLS-hSsu72 was transfected in the presence
orabsenceofGAL-Rb(repressor)orGAL-myc(activator)(data
notshown).Theseresultssuggestthatlikeinyeast,hSsu72may
target speciﬁc promoters,yet tobe deﬁned inmammals, or that
thehighexpressionoftheendogenousproteinrendersthetrans-
fection of additional nuclear hSsu72 inconsequential.
Mammalian ssu72 is unable to functionally complement
its homolog in S.cerevisiae
The conservation between human and yeast Ssu72 in primary
sequence, binding partners, phosphatase activity and subcel-
lular localization on the one hand, but dynamic regulation and
non-essential function in COS7 cells on the other, prompted us
to ask whether hssu72 could functionally complement an
ssu72 mutation in yeast. To test this possibility, we used
yeast RF79977, a diploid strain with one ssu72 allele inacti-
vated by insertion of a neo
R marker (30). Sporulation of
RF79977 transformants for pRS316-yssu72, a CEN+ vector
carrying the yeast ssu72 genomic locus spanning the promoter
and coding regions, resulted in the recovery of four viable
spores (Figure 8A). Upon replica plating into G418 containing
Figure 8. Humanssu72doesnotrescuessu72-lethalmutationinyeast.(A)Assu72(+/ )diploidyeast(RF79977)transformedwiththeyeastssu72locus(including
promoter and coding region in pRS316 vector), the human ssu72 gene under control of a galactose-inducible promoter (pYES) or parental vectors were induced to
sporulate. Upon sporulation, ssu72  spores died, giving rise to two ssu72+ colonies. Expression of yeast Ssu72 rescued the ssu72 lethal defect resulting in four
coloniespertetrad,twoofwhichcontainedthessu72
 neo
RalleleasrevealedbyreplicaplatingontoG418-plates(datanotshown).Incontrast,hSsu72expressingand
the parentalvectors failed to rescue, yielding only two clones per tetrad, which were both G418-sensitive (i.e. expressing wild-type endogenous yeast ssu72 allele).
(B) Western blot analysis of RF79977 yeast ssu72(+/ ) transformants grown in the presence of galactose showing high expression of the human Ssu72 in yeast.
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 :neo
R allele, two
spores survived (data not shown), indicating complementation
of the ssu72 defect. In contrast, transformants for the human
ssu72 gene induced from a galactose responsive promoter
(pYES-hssu72) or the parental vectors pYES and pRS316
gave rise to only two viable spores per tetrad (Figure 8A).
None of these clones survived when replica plated onto G418-
plates, indicating that they contained the yeast wt ssu72 allele.
Western blot analysis conﬁrmed that Myc-tagged and
untagged human ssu72 alleles were highly expressed in the
RF79977 yeast transformants (Figure 8B). Thus, under these
conditions, human ssu72 was unable to complement the loss of
its homolog in yeast.
DISCUSSION
We here describe the molecular identiﬁcation of a human
homolog of Ssu72 as a novel partner for pRb. We also
show that hSsu72 interacts with TFIIB and yeast Pta1. The
interaction ofpRb with hSsu72 may represent anovel mechan-
ism of transcriptional regulation. Notably, BRCA1 associates
with the polyadenylation factor CstF-50 (44,45), suggesting
common regulation of RNA processing by tumor suppressors.
Interaction of pRb with hSsu72 involves multiple domains but
is independent of the LxCxE-binding domain. This suggests a
model in which pRb may concomitantly repress certain
transcriptional activators by masking their trans-activation
domain, recruit chromatin modifying enzymes via the
LxCxE-binding domain and sequester hSsu72, thereby
inhibiting spurious transcription activation/RNA processing.
Interestingly, the B subdomain of pRb shares sequences
similarities with the C-terminal domain of TFIIB (46).
Thus, pRb may mimic TFIIB and inhibit its interaction
with hSsu72. However, in multiple assays including reporter
assays and co-localization in co-transfection experiments,
Saos-2 cell suppression assays, phosphatase inhibition assays
and protein-interference experiments, we were unable to
demonstrate any effect of pRb on hSsu72 activity or vice
versa. Identiﬁcation of hSsu72 responsive genes may allow
us to test the effect of pRb on this protein.
An insight into where Ssu72 may be critical has emerged
from our in situ hybridization analysis. During embryogenesis,
mouse ssu72 is highly expressed only during neurogenesis and
gut development (Figure 7). Notably, the expression pattern of
mouse ssu72 in the nervous system overlaps the expression
pattern of Rb during embryogenesis (35,47). Inactivation of
several PIC-associated factors, including mTAFII105, dTA-
FII80, TAFII30 and mTRF2 results in tissue-speciﬁc defects
(48–51). For example, gene-disruption reveals that TAFII105
is speciﬁcally required in ovarian development (52). The gen-
eration of a mouse knockout model for ssu72 may identify
tissues such as the nervous system and intestine where Ssu72
may play a non-redundant role. Such knockout mice may
facilitate the identiﬁcation of target genes for Ssu72 and
allow further investigation into the combined effects of pRb
and Ssu72 on transcription and RNA processing.
The phylogenetic conservation among Ssu72 gene products
is remarkable (Figure 1). Nonetheless, whereas Ssu72 is essen-
tial in yeast, siRNA mediated suppression of its expression in
COS7 cells resulted in no obvious effect on proliferation or
viability under our experimental conditions (Figures SD-2).
Inactivation of mammalian Ssu72 may inhibit the expression
of only a subset of genes without compromising cell growth.
Alternatively, it may play redundant roles with functionally,
though not structurally, related genes. This possibility is
supported by the observation that the Fcp1 phosphatase can
rescue the ssu72 lethal mutation in yeast (12). In addition, a
recently identiﬁed novel RNA polymerase II C-terminal Ser-5
phosphatase, SCP (53), may also play a redundant role with
Ssu72. In certain cell types, Fcp1, SCP or other phosphatases
may be expressed at sufﬁcient levels to substitute for Ssu72
when the latter is absent or experimentally knockdown as in
our siRNA experiments.
Despite the conservation in sequence, biological partners
and biochemical functions, the human Ssu72 failed to com-
plement an ssu72 mutation in yeast (Figure 8). Perhaps, only
certain regions of hSsu72 cannot function in yeast. Indeed,
while the ﬁrst two-thirds of Ssu72 are highly conserved, the
C-terminus is diverged across species. In particular, there are
eight amino acids in the C-terminus of S.cerevisiae, which are
not found in Schizosaccharomyces pombe, Drosophila
melanogaster or Homo sapiens (Figure 1B; data not
shown). Swapping of the human 30 amino acid at the
C-terminus with the yeast C-terminal 45 amino acid or a series
of N-to-C and C-to-N human-yeast Ssu72 hybrids may iden-
tify functionally conserved/non-conserved regions across
these species. Interestingly, human TFIIB, which is also
phylogenetically conserved, fails to complement yeast
TFIIB mutant; swapping analysis revealed only a small
non-conserved subdomain (54).
We found that both endogenous and ectopically expressed
mammalian Ssu72 resided primarily in the cytoplasm and to a
lesser extent in the nucleus (Figure 6). Since there is no
obvious NLS in Ssu72, it is possible that it translocates into
the nucleus by a ‘piggyback’ mechanism. However, in pre-
liminary results, we have found that co-transfection with pRb
or Myc-Pta1 did not confer obvious nuclear localization upon
hSsu72 (data not shown). Alternatively, due to its small size,
Ssu72 may freely diffuse into the nucleus and be actively
exported into the cytoplasm. Although we found no change
in subcellular localization of hSsu72 in response to the Crm1
inhibitor Leptomycin B (data not shown), we cannot rule out
the possibility that Ssu72 is regulated by nuclear export via
other exportins. Indeed, CRM1-independent nuclear export
signals have been mapped in various proteins, such as VHL
and the RNA processing factors hnRNPA1, hnRNP K and Hur
(55). Usually, cytoplasmic proteins readily translocate into the
nucleus when fused to strong NLSs (56,57). In contrast, fusion
of hSsu72 to a strong NLS induced nuclear localization in 45%
of transfected cells, whereas in the rest NLS-hSsu72 localized
in the cytoplasm or throughout the cell (Figure 6E). The reten-
tion ofNLS-hSsu72inthe cytoplasmof 45–55% oftransfected
cells suggests the existence of an active mechanism that
tethers hSsu72 in the cytosol.
The partial nuclear localization of Ssu72 combined with its
interaction with nuclear factors, such as pRb and TFIIB, sug-
gest a nuclear function to this protein. Certain signals, yet to be
discovered, may induce complete translocation of Ssu72 into
the nucleus and lead to robust activation or repression of gene
expression. Alternatively, Ssu72 may exert two independent
functions: transcription/RNA processing in the nucleus and as
yet to be deﬁned activity in the cytoplasm. In this regards, it is
Nucleic Acids Research, 2005, Vol. 33, No. 2 475interesting to note that the closest mammalian homolog of
Pta1, albeit with very weak similarity, is symplekin, a dual
residenceproteinthatlocalizesinthenucleusaswellasintight
junctions, adherens junctions or desmosomes (58). In the
nucleus, it is involved in 30 end processing, bringing CPSF
and CStF to the same complex (59,60). Further studies will
determine whether Ssu72 has a ‘cytoplasmic function’ and
whether its activities in both compartments are orchestrated
in the course of speciﬁc biological processes, such as neuronal
and gut development.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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